
Hua Medicine (Shanghai) Ltd.
Hua Medicine (Shanghai) Ltd.(HUMDF)股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · HUMDF · 截至 Jun 9, 2026
关键指标
探索 Hua Medicine (Shanghai) Ltd. 数据
humdf stock data · financials财务快照
完整财报竞争对手与同行
humdf competitors股票表现
完整历史关于 Hua Medicine (Shanghai) Ltd.
Hua Medicine (Shanghai) Ltd. is a clinical-stage pharmaceutical firm specializing in treatments for diabetes, primarily targeting the Chinese market. Its flagship product is Dorzagliatin (also known a…
what is hua medicine (shanghai) ltd. · humdf stock overview · hua medicine (shanghai) ltd. company profile · who is hua medicine (shanghai) ltd. ceo · humdf OTC · hua medicine (shanghai) ltd. headquarters · hua medicine (shanghai) ltd. business segments
关于股票概览与关键数据
Hua Medicine (Shanghai) Ltd.(HUMDF)是 Drug Manufacturers - Specialty & Generic 行业的 Healthcare 类公司,于 Mar 15, 2021 在 OTC 上市。截至最近交易日,HUMDF 股价为 $0.41,市值约为 $409.3M。过去12个月累计回报 +173.80%,年初至今回报 +0.00%。
2025 财年 Hua Medicine (Shanghai) Ltd. 营收 $480.2M。完整财务数据(营收历史、盈利、资产负债表)请使用上方标签页。
常见问题
截至最近一个交易日,Hua Medicine (Shanghai) Ltd.(HUMDF)股价为 $0.41,在 OTC 上市,52周区间为 $0.15 – $0.50。